Bioethica Forum is an interdisciplinary journal focussing on ethical issues in health care, research, biotechnologies, and public health. These questions are considered in relation to concrete ethical, legal and policy problems, or in terms of the fundamental concepts, principles and theories used in discussions of such problems. The journal aims to publish high-quality academic papers that will stimulate debate about these issues. It also aims to provide a discussion forum on ethical issues for health care providers, researchers, and members of research ethics and clinical ethics committees, and offers special sections for this purpose. Although specific relevance to current Swiss debates is an advantage, it is not a pre-requisite as the journal aims for an international readership. The journal's languages are German, French, and English. Abstracts are published in all three languages. Manuscripts are accepted for publication on the understanding that they have been submitted solely to Bioethica Forum and that they have not been previously published either in whole or in part. Bioethica Forum is the official journal of the Swiss Society for Biomedical Ethics.
Bioethica Forum follows the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.
Manuscript lengths include abstract, references, and footnotes. Spaces are included.
Articles should be up to 30'000 characters, with up to five tables and figures. Manuscripts reporting empirical studies should be submitted with a structured abstract of up to 250 words. Manuscripts presenting a conceptual exploration, analysing a current controversy, or critically appraising a method in bioethics, should be submitted with an unstructured abstract of up to 150 words. Articles are peer-reviewed.
Ethics case commentaries should be should be up to 20'000 characters, with a brief summary of up to 100 words, and up to three tables and figures. Interdisciplinary commentaries from multiple authors are encouraged. Case commentaries are peer-reviewed.
Letters to the editor should be no more than 3'000 characters, with up to 5 references and one table or figure. Letters in response to a published article may be submitted for up to 2 months after publication.
Review articles should be up to 30'000 characters, with up to three tables and figures. Manuscripts reporting the state of the art on a topic of interest to bioethics should be submitted with an unstructured abstract of up to 150 words. Review articles will be reviewed internally.
Viewpoints, or dEthical narratives, (personal vignettes or narratives exploring an aspect of clinical ethics, research ethics, or public health ethics) should be no more than 10'000 characters. Viewpoints and narratives will be reviewed internally. Please contact to discuss your proposal.
Book reviews should be no more than 3'000 characters and include the following elements: title, field, audience, purpose, content, highlights, limitations, and related reading. Please contact to discuss your proposal.
Committee reports: Clinical ethics committees and research ethics committees can submit an argued summary of one of their guidelines or opinions, or an argued position on a practical point of research review. Please contact to discuss your proposal.
Submissions are accepted in German, French, or English. Manuscripts should be double-spaced. All self-identifying information should be removed from manuscripts and should appear on the title page only. Abbreviations should be explained at the first occurrence.
All manuscript submissions and queries should be sent electronically to
. Please indicate in your cover letter if your submission applies to an announced theme issue.
Please include in your cover letter:
In house review:
Authorship is reserved for persons who make a substantial contribution to and who accept responsibility for a published work, according to the criteria outlined in the International Committee of Medical Journal Editors (ICMJE) recommendations and by the Swiss Academies of Arts and Sciences.
Conflict of interests
Bioethica Forum complies with the International Committee of Medical Journal Editors ("Uniform Requirements for Manuscripts Submitted to Biomedical Journals") which states that :
«Conflict of interest exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.»